AOA Dx Analysis: $17M Raised
What is AOA Dx?
AOA Dx specializes in early cancer detection using AI-driven platforms, focusing on women's health through multi-omics technology and tumor marker gangliosides.
Employees
25
Founded
2020
Revenue
$5.7M
Company Stage
Series A
YC Batch
S21
Product Features & Capabilities
- GlycoLocate™: multi-omics platform for early cancer detection, AKRIVIS GD™: blood test for early-stage ovarian cancer detection
How much AOA Dx raised
1 - $17 million
October 12, 2023Lead Investor: Good Growth Capital, RH, and others
Who are the founders of AOA Dx
OP
Oriana Papin-Zoghbi
CEO & Co-Founder
AF
Alex Fisher
COO & Co-Founder
AJ
Anna Jeter
Chief Business Officer & Co-Founder
Investors
- Avestria Ventures
- AlleyCorp
- The Helm
- RH Capital
